Peters, K <br/><br/>
Supportive use of amifostine in patients with head and neck tumors undergoing radio-chemotherapy. Is it possible to limit the duration of the application of amifostine?  [electronic resource] 

 -  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]  Nov 1999 
 - 23-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0179-7158 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Amifostine--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Carboplatin--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Combined Modality Therapy<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Leukocyte Count<br/>Middle Aged<br/>Platelet Count<br/>Prognosis<br/>Radiation-Protective Agents--administration & dosage<br/>Radiodermatitis--etiology<br/>Radionuclide Imaging<br/>Radiotherapy--adverse effects<br/>Radiotherapy Dosage<br/>Salivary Glands--diagnostic imaging<br/>Skin Temperature<br/>Time Factors